1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,830 | 1,950 | 15.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.03. | Careium AB: Tove Christiansson joins as CEO of Careium on June 1 | 136 | GlobeNewswire (Europe) | As earlier communicated, Tove Christiansson has been appointed CEO of Careium. Her first day in office will be June 1.
Tove holds a bachelor's degree from Lund University and brings over 20 years of... ► Artikel lesen | |
| 11.02. | Careium AB: Careium reports fourth quarter results 2025 | 252 | GlobeNewswire (Europe) | Summary fourth quarter 2025Net sales increased by 0.9 percent to SEK 230.9 million (228.9)Net sales increased by 6.3 percent adjusted for currency effectsNet sales increased by 13.1 percent adjusted... ► Artikel lesen | |
| 11.12.25 | Careium AB: Careium comments on full-year results | 190 | GlobeNewswire (Europe) | Careium's operations are developing well, however we are currently experiencing longer sales cycles than expected in UK and Germany for product sales. This impacts net sales, profitability and cashflow.... ► Artikel lesen | |
| 02.12.25 | Careium AB: Tove Christiansson appointed CEO of Careium | 250 | GlobeNewswire (Europe) | The Board of Directors of Careium has appointed Tove Christiansson as the CEO, effective Q2 2026. She succeeds interim CEO Peter Heuman, who will remain in his current role until the transition has... ► Artikel lesen | |
| 24.10.25 | Careium AB: Careium reports third quarter results 2025 | 180 | GlobeNewswire (Europe) | The third quarter in summaryNet sales increased by 6.0 percent to SEK 213.7 million (201.7)Net sales increased by 9.4 percent adjusted for currency effectsNet sales increased despite a negative impact... ► Artikel lesen | |
| 18.08.25 | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 383 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 11.07.25 | Careium AB: Careium reports second quarter results 2025 | 250 | GlobeNewswire (Europe) | The second quarter in summary
Net sales decreased 11.9 percent to SEK 202.1 million (229.4)Reported net sales was negatively impacted with SEK 15.1 million by the accounting of financial leases in Sweden... ► Artikel lesen | |
| 13.06.25 | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 215 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| 24.04.25 | Careium AB: Careium reports first quarter results 2025 | 192 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,030 | -1,83 % | Fresenius: S&P Global erhöht Ausblick - jetzt zugreifen? | Unter der Leitung von Konzernchef Michael Sen hat sich Fresenius einem Umbau unterzogen. Randbereiche wurden verkauft, die Effizienz gesteigert und schlussendlich auch der Schuldenabbau forciert. Das... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,340 | +0,13 % | SIEMENS HEALTHINEERS AG im strategischen Gleichgewicht | ||
| THERMO FISHER | 449,90 | +0,58 % | Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities | ||
| EUROFINS SCIENTIFIC | 69,34 | +1,23 % | Eurofins Scientific To Divest Electrical & Electronic Testing Business | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins Scientific SE (EUFI.PA, ERF.PA) announced the signing of an agreement to divest its Electrical & Electronic Testing business, or MET Labs, to UL... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| DAVITA | 122,00 | -3,79 % | DaVita: The Doctor Will See You Now: The Value of Human Connection in AI-Supported Medicine | As artificial intelligence (AI) continues to take hold across all industries, Adam Weinstein, MD, chief medical information officer for DaVita, highlights how new technological capabilities also help... ► Artikel lesen | |
| DENTSPLY SIRONA | 10,240 | -1,06 % | Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received... ► Artikel lesen | |
| SMITH & NEPHEW | 14,800 | +0,68 % | Smith & Nephew Plc: Smith+Nephew's REGENETEN? Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* | Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,402 | +1,76 % | SONIC HEALTHCARE LIMITED: Change in substantial holding | ||
| DIASORIN | 62,92 | -0,25 % | DiaSorin FY Net Result Down | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI, DSRLF, DIAS.MI) reported that its net result for fiscal year 2025 declined to 150 million euros from 187 million euros last year.But net revenues for... ► Artikel lesen | |
| FULGENT GENETICS | 13,700 | +2,24 % | Fulgent Genetics completes $56.9M pathology lab acquisitions | ||
| IMPLANTICA | 4,505 | +1,12 % | Implantica publishes Year-end Report, January - December 2025 (Q4) | VADUZ, Liechtenstein, March 26, 2026 /PRNewswire/ --
RefluxStop US Launch Coming Closer, pending FDA approvalSignificant events in the fourth quarter FDA completed six pre-approval... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 3,660 | +2,81 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results | Lead program VMT-a-NET in neuroendocrine tumors continues to demonstrate a favorable tolerability profile with durable disease control and deepening of tumor response with longer follow-up, as reported... ► Artikel lesen | |
| OMNICELL | 31,600 | +1,94 % | Benchmark reiterates Omnicell stock rating on product cycle outlook | ||
| LEVITEE LABS | 0,010 | -100,00 % | CSE Bulletin: Delist - Levitee Labs Inc. (LVT) | Toronto, Ontario--(Newsfile Corp. - Le 26 janvier/January 2026) - The common shares of Levitee Labs Inc. will be delisted from the CSE at market close today, January 26, 2026. Levitee Labs... ► Artikel lesen |
CAREIUM AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,005 (-0,28 %) liegt der Kurs bei 1,785 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.